Page last updated: 2024-11-02

orphenadrine and Substance-Related Disorders

orphenadrine has been researched along with Substance-Related Disorders in 11 studies

Orphenadrine: A muscarinic antagonist used to treat drug-induced parkinsonism and to relieve pain from muscle spasm.
orphenadrine : A tertiary amino compound which is the phenyl-o-tolylmethyl ether of 2-(dimethylamino)ethanol.

Substance-Related Disorders: Disorders related to substance use or abuse.

Research Excerpts

ExcerptRelevanceReference
"The primary analysis quantified opioid overdose risk across 7 prescription opioid-skeletal muscle relaxant therapies and a negative control outcome (sepsis) to assess potential confounding by unmeasured illicit opioid use."1.72Comparative Risk of Opioid Overdose With Concomitant Use of Prescription Opioids and Skeletal Muscle Relaxants. ( Barnett, ML; Bykov, K; Gagne, JJ; Glynn, RJ; Khan, NF; Vine, SM, 2022)
"Norjizak is a new drug abused in the past few years in Iran with symptoms and complications distinct from other common forms of drug and characterized by higher rate of mortality."1.42A tentative component analysis of Norjizak: A new abused drug in Iran. ( Farhoudian, A; Fekri, M; Movaghar, AR; Rahimzadeh, S; Sadeghi, M; Sefatian, S; Vishteh, HR, 2015)
"This outnumbered sales to patients with Parkinson's disease by >20 to 1."1.35The use and potential abuse of anticholinergic antiparkinson drugs in Norway: a pharmacoepidemiological study. ( Bramness, JG; Gjerden, P; Slørdal, L, 2009)

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19907 (63.64)18.7374
1990's0 (0.00)18.2507
2000's2 (18.18)29.6817
2010's1 (9.09)24.3611
2020's1 (9.09)2.80

Authors

AuthorsStudies
Khan, NF1
Bykov, K1
Barnett, ML1
Glynn, RJ1
Vine, SM1
Gagne, JJ1
Sadeghi, M1
Farhoudian, A1
Vishteh, HR1
Rahimzadeh, S1
Fekri, M1
Movaghar, AR1
Sefatian, S1
Gjerden, P1
Bramness, JG1
Slørdal, L1
Pullen, GP1
Best, NR1
Maguire, J1
Buhrich, N1
Weller, A1
Kevans, P1
Shariatmadari, ME1
Bennett, NB1
Kohn, J1
Mugglestone, CJ1
Schifano, F1
Marra, R1
Magni, G1
Elmalem, J1
Garnier, R1
Nguyen Huu Chieu, R1
Bismuth, C1
Efthymiou, ML1
Johnson, J1
Milner, G1

Other Studies

11 other studies available for orphenadrine and Substance-Related Disorders

ArticleYear
Comparative Risk of Opioid Overdose With Concomitant Use of Prescription Opioids and Skeletal Muscle Relaxants.
    Neurology, 2022, 09-27, Volume: 99, Issue:13

    Topics: Amitriptyline; Analgesics, Opioid; Baclofen; Benzodiazepines; Carisoprodol; Chlorzoxazone; Cohort St

2022
A tentative component analysis of Norjizak: A new abused drug in Iran.
    Pakistan journal of pharmaceutical sciences, 2015, Volume: 28, Issue:5

    Topics: Aspirin; Betamethasone; Caffeine; Chromatography, High Pressure Liquid; Chromatography, Thin Layer;

2015
The use and potential abuse of anticholinergic antiparkinson drugs in Norway: a pharmacoepidemiological study.
    British journal of clinical pharmacology, 2009, Volume: 67, Issue:2

    Topics: Adolescent; Adult; Aged; Antiparkinson Agents; Antipsychotic Agents; Biperiden; Cholinergic Antagoni

2009
Anticholinergic drug abuse: a common problem?
    British medical journal (Clinical research ed.), 1984, Sep-08, Volume: 289, Issue:6445

    Topics: Adult; Biperiden; Female; Humans; Male; Middle Aged; Orphenadrine; Parasympatholytics; Schizophrenia

1984
Misuse of anticholinergic drugs by people with serious mental illness.
    Psychiatric services (Washington, D.C.), 2000, Volume: 51, Issue:7

    Topics: Adult; Benztropine; Female; Humans; Illicit Drugs; Male; Mental Disorders; Muscarinic Antagonists; N

2000
Letter: Orphenadrine dependence.
    British medical journal, 1975, Aug-23, Volume: 3, Issue:5981

    Topics: Adult; Epilepsy; Humans; Male; Orphenadrine; Substance-Related Disorders

1975
Case report: orphenadrine overdose cerebral manifestations treated with physostigmine.
    Anaesthesia and intensive care, 1976, Volume: 4, Issue:1

    Topics: Adult; Hallucinations; Humans; Male; Orphenadrine; Physostigmine; Substance-Related Disorders

1976
Dangers of orphenadrine in psychiatric patients.
    Lancet (London, England), 1985, Sep-14, Volume: 2, Issue:8455

    Topics: Humans; Orphenadrine; Parkinson Disease; Risk; Substance-Related Disorders

1985
Orphenadrine abuse.
    Southern medical journal, 1988, Volume: 81, Issue:4

    Topics: Adult; Humans; Male; Orphenadrine; Substance-Related Disorders

1988
[Acute poisoning by orphenadrine].
    Annales de medecine interne, 1985, Volume: 136, Issue:8

    Topics: Accidents, Home; Acute Disease; Adult; Aged; Child; Child, Preschool; Female; Humans; Male; Orphenad

1985
Psychiatric complications of amphetamine substances.
    Acta psychiatrica Scandinavica, 1966, Volume: 42, Issue:3

    Topics: Adolescent; Adult; Amitriptyline; Amphetamine; Chlordiazepoxide; Depression; Ephedrine; Female; Hall

1966